Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
PHASE3
The OnPrime study is a multi-center, randomized open-label phase 3 study ev...
Status
Recruiting
Location
The University of South Alabama, Mitchell Cancer Institute
A Study Investigating the Efficacy and Safety of the Combination of Iparomlimab and Tuvonralimab With or Without Chemotherapy in Second-line and Subsequent Treatments for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
NA
This is a single-arm, open-label, phase II study to evaluate the efficacy a...
Status
Recruiting
Location
The Second Affiliated Hospital of Hainan Medical University